Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
Go back to Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer| (NASDAQ: QTTB) | Delayed: 10.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.47 | 52 Week High | $ | |||
| Open | $10.47 | 52 Week Low | $ | |||
| Day High | $10.47 | P/E | N/A | |||
| Day Low | $10.47 | EPS | $ | |||
| Volume | 22 | |||||

